CA2303443A1 - Compositions adaptees pour un sejour prolonge dans le rhino-pharynx - Google Patents

Compositions adaptees pour un sejour prolonge dans le rhino-pharynx Download PDF

Info

Publication number
CA2303443A1
CA2303443A1 CA002303443A CA2303443A CA2303443A1 CA 2303443 A1 CA2303443 A1 CA 2303443A1 CA 002303443 A CA002303443 A CA 002303443A CA 2303443 A CA2303443 A CA 2303443A CA 2303443 A1 CA2303443 A1 CA 2303443A1
Authority
CA
Canada
Prior art keywords
composition according
nasal
fatty acid
alcohol
ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002303443A
Other languages
English (en)
Inventor
Anthony Guy Hatton
Teresita Regina Geradine Tallon
Hugh Purdie Scott
Jane Elizabeth Hilton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9719203.3A external-priority patent/GB9719203D0/en
Priority claimed from GBGB9806685.5A external-priority patent/GB9806685D0/en
Application filed by Individual filed Critical Individual
Publication of CA2303443A1 publication Critical patent/CA2303443A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des compositions destinées à l'administration d'un médicament, ces compositions étant adaptées pour un séjour prolongé dans les voies nasales, notamment dans le rhino-pharynx.
CA002303443A 1997-09-11 1998-09-03 Compositions adaptees pour un sejour prolonge dans le rhino-pharynx Abandoned CA2303443A1 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9719203.3A GB9719203D0 (en) 1997-09-11 1997-09-11 Novel composition and use
GB9719203.3 1997-09-11
GBGB9806685.5A GB9806685D0 (en) 1998-03-26 1998-03-26 Novel composition
GB9806685.5 1998-03-27
PCT/EP1998/005716 WO1999012520A1 (fr) 1997-09-11 1998-09-03 Compositions adaptees pour un sejour prolonge dans le rhino-pharynx

Publications (1)

Publication Number Publication Date
CA2303443A1 true CA2303443A1 (fr) 1999-03-18

Family

ID=26312214

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002303443A Abandoned CA2303443A1 (fr) 1997-09-11 1998-09-03 Compositions adaptees pour un sejour prolonge dans le rhino-pharynx

Country Status (4)

Country Link
EP (1) EP1033969A1 (fr)
JP (1) JP2001515850A (fr)
CA (1) CA2303443A1 (fr)
WO (1) WO1999012520A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050123576A1 (en) * 2003-12-03 2005-06-09 Ilana Lavon Mupirocin compositions for topical use, an improved process of making same and methods of using same
AR059359A1 (es) * 2006-02-09 2008-03-26 Schering Corp Formulaciones farmaceuticas que contienen pleconaril
EP2444067A1 (fr) * 2010-10-20 2012-04-25 Laboratorios Ojer Pharma S.L. Gel anhydrique comprenant muciprocin

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ200918A (en) * 1981-07-02 1985-07-31 Gist Brocades Nv Stable fatty oil-in-water emulsion cream for topical application
LU85849A1 (fr) * 1985-04-11 1986-11-05 Cird Derives benzonaphtaleniques,leur procede de preparation et leur application dans les domaines pharmaceutiques et cosmetiques
FR2580277B1 (fr) * 1985-04-15 1988-06-10 Oreal Nouveaux derives naphtaleniques a action retinoique, le ur procede de preparation et compositions medicamenteuse et cosmetique les contenant
IE59628B1 (en) * 1986-06-26 1994-03-09 Beecham Group Plc Treatment of fungal infections
KR100374462B1 (ko) * 1993-10-22 2003-06-09 스미스클라인 비참 코포레이션 신규조성물

Also Published As

Publication number Publication date
EP1033969A1 (fr) 2000-09-13
WO1999012520A1 (fr) 1999-03-18
JP2001515850A (ja) 2001-09-25

Similar Documents

Publication Publication Date Title
AU724070B2 (en) Use of mupirocin for the manufacture of a medicament for the treatment of bacterial infections associated with colonisation of the nasopharynx by pathogenic organisms
US6426363B1 (en) Calcium mupirocin sprayable formulation
AU692486B2 (en) Pharmaceutical or veterinary composition comprising mupirocin or a salt thereof in a cream base
US10993934B2 (en) Topical compositions of dutasteride
JP6903410B2 (ja) 水中油型乳化組成物
GB2050827A (en) Topical compositions comprising isorbide dinitrate
EP1174133A1 (fr) Composition pharmaceutiques contenant de mupirocine amorphe
JPH05279250A (ja) エアゾール組成物
WO1999012520A1 (fr) Compositions adaptees pour un sejour prolonge dans le rhino-pharynx
IE58042B1 (en) Improved betamethasone dipropionate cream
AU701720B2 (en) Biologically active composition
JP4066466B2 (ja) 糖アルコール類配合軟膏剤
CA2299298A1 (fr) Compositions destinees a une administration par voie nasale
KR950003611B1 (ko) 항진균 외용 이미다졸 제제
JP2011157392A (ja) プロピレングリコールおよびアルカン酸イソプロピルエステルを含む抗ウイルス製剤
US11857556B2 (en) Topical compositions of dutasteride
JP7449692B2 (ja) 油性外用組成物
CN101721418B (zh) 含有γ-谷维素的外用剂组合物
CA2022632A1 (fr) Formule pharmaceutique
JP6779730B2 (ja) 外用組成物
JP4615814B2 (ja) 風邪薬用液状外用剤およびその製造方法
JP2023090338A (ja) 乳化組成物
EP2429490B1 (fr) Émulsion huile-dans-eau de mométasone
WO1999051219A1 (fr) Derives de la pleuromutiline pour le traitement d'infections du rhino-pharynx
JP2003261414A (ja) 尿素含有組成物

Legal Events

Date Code Title Description
FZDE Dead